Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GNMK
2776
DELISTED
GenMark Diagnostics, Inc
GNMK
| $3.65M | ﹤0.01% |
759,592
+2,386
| +0.3% | +$13.2K |
|
2777
HCI Group
HCI
$2.32B
| $3.65M | ﹤0.01% |
79,999
+1,088
| +1% | +$48K |
|
2778
Aprea Therapeutics
APRE
$8.31M
| $3.64M | ﹤0.01% |
+3,970
| New | +$2.19M |
|
2779
MediciNova
MNOV
$64.5M
| $3.64M | ﹤0.01% |
540,345
-15,439
| -3% | -$116K |
|
|
BVH
2780
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $3.64M | ﹤0.01% |
152,511
+3,065
| +2% | +$70.5K |
|
2781
MeiraGTx Holdings
MGTX
$1.17B
| $3.63M | ﹤0.01% |
181,573
+11,165
| +7% | +$191K |
|
2782
Ares Capital
ARCC
$14.5B
| $3.63M | ﹤0.01% |
194,594
-3,173
| -2% | -$58.9K |
|
2783
Clear Channel Outdoor Holdings
CCO
$1.18B
| $3.63M | ﹤0.01% |
1,268,365
+7,175
| +0.6% | +$18.2K |
|
2784
Clean Energy Fuels
CLNE
$395M
| $3.61M | ﹤0.01% |
1,542,823
-28,143
| -2% | -$59.7K |
|
2785
Constellium
CSTM
$3.95B
| $3.6M | ﹤0.01% |
269,111
+15,675
| +6% | +$216K |
|
2786
Compañía de Cervecerías Unidas
CCU
$2.16B
| $3.58M | ﹤0.01% |
188,816
-95,214
| -34% | -$1.89M |
|
2787
Greenlight Captial
GLRE
$512M
| $3.57M | ﹤0.01% |
353,443
-3,187
| -0.9% | -$33K |
|
|
GCAP
2788
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $3.57M | ﹤0.01% |
903,692
-2,808
| -0.3% | -$12.1K |
|
2789
Phathom Pharmaceuticals
PHAT
$743M
| $3.56M | ﹤0.01% |
+114,426
| New | +$2.88M |
|
2790
Phreesia
PHR
$780M
| $3.56M | ﹤0.01% |
133,741
-5,101
| -4% | -$141K |
|
|
ITIC
2791
Investors Title Co
ITIC
$534M
| $3.55M | ﹤0.01% |
22,315
-456
| -2% | -$73.8K |
|
2792
SEACOR Marine Holdings
SMHI
$262M
| $3.54M | ﹤0.01% |
256,358
+5,505
| +2% | +$71.7K |
|
2793
Titan Machinery
TITN
$420M
| $3.53M | ﹤0.01% |
238,970
-385
| -0.2% | -$6K |
|
2794
Limoneira
LMNR
$250M
| $3.53M | ﹤0.01% |
183,383
-7,375
| -4% | -$141K |
|
2795
MasterCraft Boat Holdings
MCFT
$598M
| $3.52M | ﹤0.01% |
223,694
-1,787
| -0.8% | -$28.2K |
|
2796
Primis Financial Corp
FRST
$413M
| $3.52M | ﹤0.01% |
215,011
-9,479
| -4% | -$150K |
|
2797
Dianthus Therapeutics
DNTH
$6.13B
| $3.5M | ﹤0.01% |
14,413
-262
| -2% | -$49K |
|
2798
Cue Biopharma
CUE
$131M
| $3.49M | ﹤0.01% |
7,336
-119
| -2% | -$37.4K |
|
2799
Bridgewater Bancshares
BWB
$620M
| $3.48M | ﹤0.01% |
252,868
+18,349
| +8% | +$233K |
|
2800
Greif Class B
GEF.B
$4.22B
| $3.48M | ﹤0.01% |
67,181
-159
| -0.2% | -$7.89K |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.